Eastgate Biotech Corp. (ETBI)

OTCMKTS · Delayed Price · Currency is USD
0.0009
+0.0008 (800.00%)
At close: Jan 22, 2026
-80.00%
Market Cap846.29K
Revenue (ttm)137.64K
Net Income (ttm)-3.82M
Shares Out1.06B
EPS (ttm)-0.01
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume10,000
Average Volume1,361,480
Open0.0009
Previous Close0.0001
Day's Range0.0009 - 0.0009
52-Week Range0.0000 - 0.0045
Beta-4,022.93
RSI48.69
Earnings Daten/a

About Eastgate Biotech

Eastgate Biotech Corp., a development stage company, develops novel formulations of natural compounds and pharmaceutical products. The company is developing pharmaceutical products, such as Lorazepam oral spray for acute seizures emergency treatment; Ketoconazole 2% topical ointment for treatment of skin fungal infections; and Metformin chewable/ sublingual tablets for treatment of type 2 diabetes. It is also developing natural products and dietary supplements, including E-drops Nano and PURALEN that are self-nanoemulsifying compositions contai... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1999
Employees 3
Stock Exchange OTCMKTS
Ticker Symbol ETBI
Full Company Profile

Financial Performance

Financial Statements